Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/18/2003US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176452 Oral absorption
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176436 For therapy and prophylaxis of bacterial infections, or their use as antiseptics, sterilizants, or disinfectants
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176425 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
09/18/2003US20030176422 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
09/18/2003US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
09/18/2003US20030176379 Useful in the administration of a drug, therapy
09/18/2003US20030176372 Anti-virus agent
09/18/2003US20030176370 Anti-viral pyrimidine nucleoside analogues
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176319 N4-acylcytosine-1,3- dioxolane nucleosides for treatment of viral infections
09/18/2003US20030175969 Prevention infant blood disorders
09/18/2003US20030175950 RNA interference mediated inhibition of HIV gene expression using short interfering RNA
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175921 Complexing antigen, antibodies; immunoassay
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof
09/18/2003US20030175731 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175685 Using amino acid sequences to control apoptosis and prevent or treat cancer and viral infections
09/18/2003US20030175681 Inhibition of CMV infection and dissemination
09/18/2003US20030175679 Detecting modulators of ubiquitin conjugating enzyme complex formation; drug screening
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175370 Dry mixture of carbohydrates and drugs; wound healing agents
09/18/2003US20030175334 Phospholipid bodies and use thereof in medical treatment
09/18/2003US20030175313 Preparation of sterile stabilized nanodispersions
09/18/2003US20030175309 Adjuvants for use in vaccines
09/18/2003US20030175308 Adjuvants for use in vaccines
09/18/2003US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection
09/18/2003US20030175301 Rotavirus pseudoviral particles and use thereof for vectorizing proteins of nucleic acids
09/18/2003US20030175299 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections; stable oil-in-water emulsions, side effect reduction
09/18/2003US20030175298 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections
09/18/2003US20030175296 Chimaeric hepadnavirus core antigen proteins
09/18/2003US20030175293 Choline binding proteins for anti-pneumococcal vaccines
09/18/2003US20030175292 Compositions and methods for generating an immune response
09/18/2003US20030175291 Multiple and multivalent DNA vaccines in ovo
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175285 Major histocompatibility complex ligands, comprising proteins, peptides, epitopes, polypeptides, mimetics or lipopeptides, used as vaccines
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175238 Chemokine conjugates
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003CA2518586A1 Fuel additive
09/18/2003CA2478942A1 An optically active pyridine derivative and a medicament containing the same
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478846A1 Use of mixtures of lipopeptides for vaccine production
09/18/2003CA2478684A1 Dispersed solid-containing complex carbohydrate
09/18/2003CA2478415A1 A multifunctional complex for targeting specific phagocytosis of a target agent
09/18/2003CA2478401A1 Treatment of surfaces populated by bacteria
09/18/2003CA2478371A1 Compositions and methods for generating an immune response
09/18/2003CA2478245A1 Treatment and prevention of inflammatory disorders
09/18/2003CA2478121A1 Antibiotic composition
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2478029A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003CA2477982A1 Methods for entrapment of bioactive agent in a liposome or lipid complex
09/18/2003CA2477979A1 An inhalation system for treatment of intracellular infections
09/18/2003CA2476567A1 A process for the production of ramoplanin-like amide derivatives
09/18/2003CA2475738A1 Activated protein c formulations
09/18/2003CA2472119A1 Screening method for orthopoxvirus antivirals
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344533A1 Pharmaceutical compositions comprising mannose binding lectin
09/17/2003EP1344458A1 Probiotic delivery system
09/17/2003EP1343896A1 Small acid-soluble spore protein and uses thereof
09/17/2003EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments
09/17/2003EP1343888A2 Regulation of human chemokine-like receptor
09/17/2003EP1343826A1 Polysaccharide compound having immune stimulating activity
09/17/2003EP1343819A1 Hla-a2.1 binding peptides and their uses
09/17/2003EP1343815A2 Antibacterial treatments
09/17/2003EP1343814A2 Immunogenic glycopeptides, screening, preparation and uses
09/17/2003EP1343811A1 Methods for preparing purified lipopeptides
09/17/2003EP1343807A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
09/17/2003EP1343803A2 2-substituted estrogens as antiangiogenic agents
09/17/2003EP1343799A1 14-membered macrolides derived from leucomycins
09/17/2003EP1343798A1 6-o-carbamoyl ketolide derivatives of erythromycin useful as antibacterials
09/17/2003EP1343797A1 Macrolide antibiotics
09/17/2003EP1343790A2 Cephalosporin production
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343784A2 Urea substituted imidazoquinoline ethers
09/17/2003EP1343783A2 Substituted imidazopyridines
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343780A1 Piperazine derivatives for treatment of bacterial infections
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343765A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343753A2 Antimicrobial agents
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343544A2 Uses of a medical device having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders
09/17/2003EP1343528A2 Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4
09/17/2003EP1343527A2 Adjuvant combination formulations
09/17/2003EP1343525A2 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE
09/17/2003EP1343520A2 New therapeutic uses of smr1 peptides
09/17/2003EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
09/17/2003EP1343516A2 Analogues of thiocoraline and be-22179
1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 1798